Free Trial
NASDAQ:UG

United-Guardian (UG) Stock Price, News & Analysis

United-Guardian logo
$9.92 +0.16 (+1.64%)
As of 01/3/2025 05:22 PM Eastern

About United-Guardian Stock (NASDAQ:UG)

Key Stats

Today's Range
$9.74
$9.92
50-Day Range
$9.54
$13.89
52-Week Range
$7.02
$16.25
Volume
5,542 shs
Average Volume
5,371 shs
Market Capitalization
$45.53 million
P/E Ratio
13.05
Dividend Yield
7.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.

United-Guardian Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
21st Percentile Overall Score

UG MarketRank™: 

United-Guardian scored higher than 21% of companies evaluated by MarketBeat, and ranked 878th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for United-Guardian.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of United-Guardian is 13.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.08.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of United-Guardian is 13.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 87.84.

  • Price to Book Value per Share Ratio

    United-Guardian has a P/B Ratio of 4.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.47% of the float of United-Guardian has been sold short.
  • Short Interest Ratio / Days to Cover

    United-Guardian has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in United-Guardian has recently increased by 32.69%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    United-Guardian is a leading dividend payer. It pays a dividend yield of 7.16%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    United-Guardian has only been increasing its dividend for 1 years.

  • Dividend Coverage

    The dividend payout ratio of United-Guardian is 92.11%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about United-Guardian's dividend.
  • Percentage of Shares Shorted

    0.47% of the float of United-Guardian has been sold short.
  • Short Interest Ratio / Days to Cover

    United-Guardian has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in United-Guardian has recently increased by 32.69%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 2 people have searched for UG on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, United-Guardian insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    29.00% of the stock of United-Guardian is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 23.16% of the stock of United-Guardian is held by institutions.

  • Read more about United-Guardian's insider trading history.
Receive UG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for United-Guardian and its competitors with MarketBeat's FREE daily newsletter.

UG Stock News Headlines

United-Guardian Posts Rising Q3 Earnings
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
United-Guardian Reports Increased Third Quarter Earnings
Gold Rises on Possible Technical Recovery
See More Headlines

UG Stock Analysis - Frequently Asked Questions

United-Guardian's stock was trading at $9.56 at the start of the year. Since then, UG stock has increased by 3.8% and is now trading at $9.92.
View the best growth stocks for 2025 here
.

United-Guardian, Inc. (NASDAQ:UG) released its quarterly earnings data on Friday, November, 8th. The company reported $0.19 EPS for the quarter. The firm earned $3.06 million during the quarter. United-Guardian had a trailing twelve-month return on equity of 30.25% and a net margin of 28.30%.

Shares of UG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that United-Guardian investors own include Comtech Telecommunications (CMTL), Plug Power (PLUG), Alamos Gold (AGI), Workhorse Group (WKHS), Fortress Biotech (FBIO), FuelCell Energy (FCEL) and KALA BIO (KALA).

Company Calendar

Last Earnings
11/08/2024
Today
1/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Toilet preparations
Sub-Industry
Consumer Goods
Employees
20
Year Founded
N/A

Profitability

Net Income
$2.58 million
Pretax Margin
35.73%

Debt

Sales & Book Value

Annual Sales
$12.31 million
Cash Flow
$0.59 per share
Book Value
$2.48 per share

Miscellaneous

Free Float
N/A
Market Cap
$45.53 million
Optionable
Not Optionable
Beta
0.75

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NASDAQ:UG) was last updated on 1/5/2025 by MarketBeat.com Staff
From Our Partners